Trial intelligence / Profile preview

Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets in Healthy Thai Volunteers

TCTR20260128007Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of rivaroxaban (2 arms), sponsored by International Bio Service. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

rivaroxaban

Beyond the preview

Go deeper on TCTR20260128007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260128007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call